Zimmer Biomet Holdings (ZBH) Operating Expenses (2009 - 2026)

Zimmer Biomet Holdings has reported Operating Expenses for 18 years, with the latest figure at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 5.98% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $7.2 billion (up 13.21% YoY), and the FY2025 full-year result was $7.1 billion, up 11.58% from the prior year.
• Operating Expenses for Q1 2026 stood at $1.7 billion, down from $2.1 billion in the prior quarter.
• The five-year high for Operating Expenses was $2.1 billion in Q4 2025, with the low at $1.4 billion in Q3 2022.
• Average Operating Expenses over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2024.
• Year-over-year, Operating Expenses fell 14.43% in 2023 and increased 27.84% in 2025.
• Tracing ZBH's Operating Expenses over 5 years: stood at $1.9 billion in 2022, then fell by 14.43% to $1.6 billion in 2023, then increased by 3.05% to $1.6 billion in 2024, then climbed by 27.84% to $2.1 billion in 2025, then fell by 17.99% to $1.7 billion in 2026.
• The last three Operating Expenses figures came in at $1.7 billion (Q1 2026), $2.1 billion (Q4 2025), and $1.7 billion (Q3 2025), per Business Quant data.

Peer Comparison